Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-17-311168
Filing Date
2017-10-17
Accepted
2017-10-17 06:02:06
Documents
5
Period of Report
2017-10-17

Document Format Files

Seq Description Document Type Size
1 6-K d472469d6k.htm 6-K 9043
2 EX-99.1 d472469dex991.htm EX-99.1 265513
3 GRAPHIC g472469002.jpg GRAPHIC 4642
4 GRAPHIC g472469003.jpg GRAPHIC 5272
5 GRAPHIC g4724691a.jpg GRAPHIC 11960
  Complete submission text file 0001193125-17-311168.txt   306080
Mailing Address LEVEL 12, 95 PITT STREET SYDNEY, NEW SOUTH WALES C3 2000
Business Address LEVEL 12, 95 PITT STREET SYDNEY, NEW SOUTH WALES C3 2000 612 9276 1224
Prima BioMed Ltd (Filer) CIK: 0001506184 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35428 | Film No.: 171139786
SIC: 2834 Pharmaceutical Preparations